KCL Philosophy is advertising a 3 year post for the
Sowerby Lecturer in Philosophy of Medicine:
my.corehr.com/pls/kclrecru...
#philsky #philjobs
Sowerby Lecturer in Philosophy of Medicine:
my.corehr.com/pls/kclrecru...
#philsky #philjobs
my.corehr.com
November 3, 2026 at 2:09 PM
KCL Philosophy is advertising a 3 year post for the
Sowerby Lecturer in Philosophy of Medicine:
my.corehr.com/pls/kclrecru...
#philsky #philjobs
Sowerby Lecturer in Philosophy of Medicine:
my.corehr.com/pls/kclrecru...
#philsky #philjobs
KCL pošljem mejl oni mi pošljejo termin. Ne vem, kako je drugje.
November 2, 2026 at 11:06 AM
KCL pošljem mejl oni mi pošljejo termin. Ne vem, kako je drugje.
KCL on psyops.
www.youtube.com/watch?v=vBLt...
www.youtube.com/watch?v=vBLt...
It’s political theater, hold the line
YouTube video by Knitting Cult Lady
www.youtube.com
October 31, 2026 at 2:08 AM
KCL on psyops.
www.youtube.com/watch?v=vBLt...
www.youtube.com/watch?v=vBLt...
I'll be joined by
@hancock2001.bsky.social as well as two terrific scholars, Jonathan Davis (Anglia Ruskin) and Eva Nieto McAvoy (KCL)
@hancock2001.bsky.social as well as two terrific scholars, Jonathan Davis (Anglia Ruskin) and Eva Nieto McAvoy (KCL)
October 30, 2026 at 10:56 AM
I'll be joined by
@hancock2001.bsky.social as well as two terrific scholars, Jonathan Davis (Anglia Ruskin) and Eva Nieto McAvoy (KCL)
@hancock2001.bsky.social as well as two terrific scholars, Jonathan Davis (Anglia Ruskin) and Eva Nieto McAvoy (KCL)
So KCL and Cranfield are merging, joining City St George's and Grent.
The dusk at the end of the UK academy is real rollercoaster...
The dusk at the end of the UK academy is real rollercoaster...
November 2, 2026 at 12:38 PM
So KCL and Cranfield are merging, joining City St George's and Grent.
The dusk at the end of the UK academy is real rollercoaster...
The dusk at the end of the UK academy is real rollercoaster...
0,0 + zero = 15 kcl
Prost!
Prost!
October 31, 2026 at 8:40 PM
0,0 + zero = 15 kcl
Prost!
Prost!
Timely! Our next Greek Play will be Medea. The KCL Greek Play has been an annual tradition since 1953 and it is the only production in the country to be performed every year in the original Greek. 🏺
Medea | Greenwood Theatre | March 9-11th | tickets coming soon 🎟️
Medea | Greenwood Theatre | March 9-11th | tickets coming soon 🎟️
On Instant Classics this week, we explore Medea, first of all through Euripides' extraordinary play. How do we understand mothers who kill their children? It's still a question for us www.youtube.com/watch?v=kEZv...
Medea 1: Child killer
YouTube video by Instant Classics
www.youtube.com
November 3, 2026 at 10:53 AM
Timely! Our next Greek Play will be Medea. The KCL Greek Play has been an annual tradition since 1953 and it is the only production in the country to be performed every year in the original Greek. 🏺
Medea | Greenwood Theatre | March 9-11th | tickets coming soon 🎟️
Medea | Greenwood Theatre | March 9-11th | tickets coming soon 🎟️
5N-KCL, VivaJets. Another Legacy 600 joined the growing fleet. Image source: www.instagram.com/bosunola_que....
October 28, 2026 at 9:53 PM
5N-KCL, VivaJets. Another Legacy 600 joined the growing fleet. Image source: www.instagram.com/bosunola_que....
Some Draconian measures need to be enacted around plastic or none of what we do is going to matter, anyway. --KCL
October 30, 2026 at 12:55 PM
Some Draconian measures need to be enacted around plastic or none of what we do is going to matter, anyway. --KCL
My interview with Dr John Callanan (KCL) about his book, _Man-Devil: The Mind and Times of Bernard Mandeville, the Wickedest Man in Europe_ (Princeton UP), for "New Books in Philosophy":
newbooksnetwork.com/man-devil
#philsky
#philosophy
#poltheory
#polphil
#moralphil
@newbooksnetwork.bsky.social
newbooksnetwork.com/man-devil
#philsky
#philosophy
#poltheory
#polphil
#moralphil
@newbooksnetwork.bsky.social
Man-Devil: The Mind and Times of Bernard Mandeville, the Wickedest Man in Europe with John Callanan (Princeton UP, 2025) - New Books Network
newbooksnetwork.com
November 2, 2026 at 4:45 PM
My interview with Dr John Callanan (KCL) about his book, _Man-Devil: The Mind and Times of Bernard Mandeville, the Wickedest Man in Europe_ (Princeton UP), for "New Books in Philosophy":
newbooksnetwork.com/man-devil
#philsky
#philosophy
#poltheory
#polphil
#moralphil
@newbooksnetwork.bsky.social
newbooksnetwork.com/man-devil
#philsky
#philosophy
#poltheory
#polphil
#moralphil
@newbooksnetwork.bsky.social
🤑 Budget Minicast! 🤑 It was billed as the “boring” Budget and, to be fair, Chancellor John Healey mostly delivered...
KCL economist @jdportes.bsky.social and @nndroid.bsky.social get into exactly what was announced – and what it means for YOU.
Listen: linktr.ee/ohgodwhatnow...
KCL economist @jdportes.bsky.social and @nndroid.bsky.social get into exactly what was announced – and what it means for YOU.
Listen: linktr.ee/ohgodwhatnow...
October 28, 2026 at 5:45 PM
🤑 Budget Minicast! 🤑 It was billed as the “boring” Budget and, to be fair, Chancellor John Healey mostly delivered...
KCL economist @jdportes.bsky.social and @nndroid.bsky.social get into exactly what was announced – and what it means for YOU.
Listen: linktr.ee/ohgodwhatnow...
KCL economist @jdportes.bsky.social and @nndroid.bsky.social get into exactly what was announced – and what it means for YOU.
Listen: linktr.ee/ohgodwhatnow...
Pesquisadores do King's College London estão avançando nos testes do KCL-286, que visa combater danos ao DNA e inflamação no Alzheimer. Após testes em camundongos, o fármaco já passou por testes iniciais em humanos. Agora,
https://ginganoticias.com.br/farmaco-kcl-286-dano-dna-inflamacao-alzheimer/
https://ginganoticias.com.br/farmaco-kcl-286-dano-dna-inflamacao-alzheimer/
November 3, 2026 at 4:21 AM
Pesquisadores do King's College London estão avançando nos testes do KCL-286, que visa combater danos ao DNA e inflamação no Alzheimer. Após testes em camundongos, o fármaco já passou por testes iniciais em humanos. Agora,
https://ginganoticias.com.br/farmaco-kcl-286-dano-dna-inflamacao-alzheimer/
https://ginganoticias.com.br/farmaco-kcl-286-dano-dna-inflamacao-alzheimer/
Yes v. true @drjoehoover.bsky.social, esp. when your host leaves early in fear of possible delays. Have seen that in multiple countries! Also remember once trying to leave London (earlyish) after talk at KCL, only to have train cancelled due 2 a fire elsewhere. Came close to sleeping at Paddington!
November 3, 2026 at 4:05 PM
Yes v. true @drjoehoover.bsky.social, esp. when your host leaves early in fear of possible delays. Have seen that in multiple countries! Also remember once trying to leave London (earlyish) after talk at KCL, only to have train cancelled due 2 a fire elsewhere. Came close to sleeping at Paddington!
Not sure where you’re based or what your salary requirements are. There are a couple of (clinical) placements roles going in the Nursing Faculty at KCL. Knowledge of the NHS and the ability to build relationships with stakeholders within it not in the JD but likely to be super helpful.
November 3, 2026 at 1:15 PM
Not sure where you’re based or what your salary requirements are. There are a couple of (clinical) placements roles going in the Nursing Faculty at KCL. Knowledge of the NHS and the ability to build relationships with stakeholders within it not in the JD but likely to be super helpful.
UCL, KCL, LSE, Imperial, Edinburgh, St Andrews, and others really had no trouble recruiting EU undergraduates. I speak as former Dean of Arts and Humanities at UCL during that time.
November 2, 2026 at 9:00 AM
UCL, KCL, LSE, Imperial, Edinburgh, St Andrews, and others really had no trouble recruiting EU undergraduates. I speak as former Dean of Arts and Humanities at UCL during that time.
Next Monday - 'Race and the Early Modern' seminar! We are delighted to be joined by Aman Williams (NYU) who will be speaking about a paper on domesticity, nonbinary gender performances, and homoeroticism around the Black Atlantic.
The work in progress will be circulated later today.
The work in progress will be circulated later today.
“As if she were his owne lawfull wife”: Marriage, Household, and the Queering of Race, 1550-1625, Aman Williams: 9th November — CEMS KCL Blog
The Race and the Early Modern seminar is delighted to be welcoming Aman Williams on 9th November to discuss a paper titled: ‘“As if she were his owne lawfull wife”: Marriage, Household, and the Queeri...
kingsearlymodern.co.uk
November 3, 2026 at 8:40 AM
Next Monday - 'Race and the Early Modern' seminar! We are delighted to be joined by Aman Williams (NYU) who will be speaking about a paper on domesticity, nonbinary gender performances, and homoeroticism around the Black Atlantic.
The work in progress will be circulated later today.
The work in progress will be circulated later today.
TUESDAY with @kcl-chaplaincy.bsky.social
* 9.30am: Morning Prayer at Denmark Hill & Waterloo
* 12pm: International Lunch at Waterloo
buff.ly/FKd1HzY
* 9.30am: Morning Prayer at Denmark Hill & Waterloo
* 12pm: International Lunch at Waterloo
buff.ly/FKd1HzY
November 3, 2026 at 8:30 AM
TUESDAY with @kcl-chaplaincy.bsky.social
* 9.30am: Morning Prayer at Denmark Hill & Waterloo
* 12pm: International Lunch at Waterloo
buff.ly/FKd1HzY
* 9.30am: Morning Prayer at Denmark Hill & Waterloo
* 12pm: International Lunch at Waterloo
buff.ly/FKd1HzY
A drug built for spinal cord injuries repaired DNA damage and cut brain inflammation in mice with Alzheimer's-like disease. KCL-286, from King's College London, targets double-strand breaks in DNA and inflammation - problems that show up early in Alzheimer's.
November 3, 2026 at 10:06 AM
A drug built for spinal cord injuries repaired DNA damage and cut brain inflammation in mice with Alzheimer's-like disease. KCL-286, from King's College London, targets double-strand breaks in DNA and inflammation - problems that show up early in Alzheimer's.
Election Day Distraction: Good news on the dementia front. A drug already OK’d for human safety (for spinal cord injuries) turns out to be Very Promising for treatment of Alzheimer’s.
Yay, Science. Support Basic Science Research.
febs.onlinelibrary.wiley.com/doi/10.1002/...
Yay, Science. Support Basic Science Research.
febs.onlinelibrary.wiley.com/doi/10.1002/...
FEBS Press
Repair of neuronal DNA damage in Alzheimer's disease by KCL-286. (A) Amyloid-β oligomers and plaques impair neuronal DNA repair pathways, leading to DNA double-strand breaks and glial activation. (B)...
febs.onlinelibrary.wiley.com
November 3, 2026 at 6:29 PM
Election Day Distraction: Good news on the dementia front. A drug already OK’d for human safety (for spinal cord injuries) turns out to be Very Promising for treatment of Alzheimer’s.
Yay, Science. Support Basic Science Research.
febs.onlinelibrary.wiley.com/doi/10.1002/...
Yay, Science. Support Basic Science Research.
febs.onlinelibrary.wiley.com/doi/10.1002/...
old friends, and maybe even start to live...
(when AO3 comes back up in 2-4 weeks, I'll post it there as well. Apologies to any AO3 readers out there)
www.furaffinity.net/view/66874666/
(when AO3 comes back up in 2-4 weeks, I'll post it there as well. Apologies to any AO3 readers out there)
www.furaffinity.net/view/66874666/
KCL - Pre-Season #1 - The Season Scrap by Micah Weil
Glenn Aurock's life was spiraling. He had a dead end job, an apartment that mocked the very term
www.furaffinity.net
October 30, 2026 at 8:25 PM
old friends, and maybe even start to live...
(when AO3 comes back up in 2-4 weeks, I'll post it there as well. Apologies to any AO3 readers out there)
www.furaffinity.net/view/66874666/
(when AO3 comes back up in 2-4 weeks, I'll post it there as well. Apologies to any AO3 readers out there)
www.furaffinity.net/view/66874666/
Pesquisadores do King's College London desenvolveram o KCL-286, um novo medicamento que repara danos no DNA e reduz a inflamação cerebral, oferecendo esperança no tratamento da doença de Alzheimer.
#medicamentoparaalzheimer #pesquisacientifica #saude #inovacao #tratamentoparaalzheimer
#medicamentoparaalzheimer #pesquisacientifica #saude #inovacao #tratamentoparaalzheimer
Novo medicamento para Alzheimer repara danos no DNA e reduz inflamação
omniletters.com
November 3, 2026 at 1:02 PM
Pesquisadores do King's College London desenvolveram o KCL-286, um novo medicamento que repara danos no DNA e reduz a inflamação cerebral, oferecendo esperança no tratamento da doença de Alzheimer.
#medicamentoparaalzheimer #pesquisacientifica #saude #inovacao #tratamentoparaalzheimer
#medicamentoparaalzheimer #pesquisacientifica #saude #inovacao #tratamentoparaalzheimer
KCL: The bad guys just aren't that super smart ...
#cults #authoritarian #midterms #election
3 min 30 seconds Nov 2, 2026
www.youtube.com/watch?v=QXsG...
#cults #authoritarian #midterms #election
3 min 30 seconds Nov 2, 2026
www.youtube.com/watch?v=QXsG...
Authoritarians Have No Plan B Why Bad Guy Operations Are So Hard to Pull Off duplicate
YouTube video by Knitting Cult Lady
www.youtube.com
November 3, 2026 at 7:00 AM
KCL: The bad guys just aren't that super smart ...
#cults #authoritarian #midterms #election
3 min 30 seconds Nov 2, 2026
www.youtube.com/watch?v=QXsG...
#cults #authoritarian #midterms #election
3 min 30 seconds Nov 2, 2026
www.youtube.com/watch?v=QXsG...
Scientists discover new Alzheimer's drug that repairs DNA damage and reduces brain inflammation
->ScienceDaily | More on "Alzheimer's disease drug development" at BigEarthData.ai | #science
->ScienceDaily | More on "Alzheimer's disease drug development" at BigEarthData.ai | #science
Scientists discover new Alzheimer's drug that repairs DNA damage and reduces brain inflammation
The drug, known as KCL-286, produced encouraging results in a mouse model of Alzheimer's disease. Unlike treatments that focus primarily on the buildup of toxic proteins in the brain, this approach targets additional processes that can begin long before the disease reaches its advanced stages. One particularly promising advantage is that KCL-286 has already completed Phase 1 human safety and tolerability trials as part of its earlier development. This could significantly shorten the path toward further clinical testing, although its effectiveness against Alzheimer's in humans has not yet been established. "KCL-286 is a first-in-class, orally bioavailable small molecule that has already successfully cleared Phase 1 human safety and tolerability trials. This will dramatically cut down the traditional multi-year timeline required for new drug development," commented Professor Jonathan Corcoran, Professor of Neuroscience at the Institute of Psychiatry, Psychology & Neuroscience at King's College London. The drug is a small molecule that can be taken by mouth, making it potentially more convenient to administer than treatments that require injections or infusions. Why Alzheimer's Disease Is So Difficult to Treat Alzheimer's disease involves a complicated series of changes in the brain, making it particularly challenging to develop effective treatments. Two of its best-known...
www.sciencedaily.com
November 3, 2026 at 6:15 AM